真人做爰48姿势视图片|少妇真人直播免费视频|日本真人做爰A片|真人裸体做爰视频|真人与拘做爰视频免费观看|真人与拘做受免费视频一

核因子κB受體激活因子(RANk)活性蛋白

Active Receptor Activator Of Nuclear Factor Kappa B (RANk)

CD265; TNFRSF11A; TNFRSF11-A; ODFR; OFE; TRANCER; Osteoclast differentiation factor receptor; Tumor Necrosis Factor Receptor Superfamily,Member 11a,NFKB Activator

  • 核因子κB受體激活因子(RANk)活性蛋白 產品包裝(模擬)
  • 核因子κB受體激活因子(RANk)活性蛋白 產品包裝(模擬)
  • 核因子κB受體激活因子(RANk)活性蛋白 Figure. Gene Sequencing (Extract)
  • APC057Hu01.png Figure. SDS-PAGE
  • 核因子κB受體激活因子(RANk)活性蛋白 Figure. Western Blot
  • Certificate 通過ISO 9001、ISO 13485質量體系認證

活性實驗

Figure. The binding activity of TNFRSF11A with TRAF5.
RANK tumor necrosis factor receptor superfamily member 11A protein (TNFRSF11A) also known as receptor Activator of Nuclear Factor κ B (RANK) or TRANCE Receptoris a member of the tumor necrosis factor receptor (TNFR) molecular sub-family. TNFRSF11A is the receptor for RANK-Ligand (RANKL) and part of the RANK/RANKL/OPG signaling pathway that regulates osteoclast differentiation and activation. It is associated with bone remodeling and repair, immune cell function, lymph node development, thermal regulation, and mammary gland development. Besides, TNF Receptor Associated Factor 5 (TRAF5) has been identified as an interactor of TNFRSF11A, thus a binding ELISA assay was conducted to detect the interaction of recombinant human TNFRSF11A and recombinant human TRAF5. Briefly, TNFRSF11A were diluted serially in PBS, with 0.01% BSA (pH 7.4). Duplicate samples of 100μL were then transferred to TRAF5-coated microtiter wells and incubated for 2h at 37℃. Wells were washed with PBST and incubated for 1h with anti-TNFRSF11A pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody, wells were aspirated and washed 3 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50μL stop solution to the wells and read at 450nm immediately. The binding activity of TNFRSF11A and TRAF5 was shown in Figure 1, and this effect was in a dose dependent manner.

用法

Reconstitute in 20mM Tris, 150mM NaCl (PH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

儲存

避免反復凍融。2-8°C不超過一個月,-80°C不超過12個月。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產生。保質期內,在適當?shù)臈l件下存儲,損失率低于5%。

相關產品

編號 適用物種:Homo sapiens (Human,人) 應用(僅供研究使用,不用于臨床診斷!)
RPC057Hu01 核因子κB受體激活因子(RANk)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
APC057Hu01 核因子κB受體激活因子(RANk)活性蛋白 Cell?culture;?Activity?Assays.
PAC057Hu01 核因子κB受體激活因子(RANk)多克隆抗體 WB,IHC
MAC057Hu22 核因子κB受體激活因子(RANk)單克隆抗體 WB; IHC; ICC; IP.
MAC057Hu21 核因子κB受體激活因子(RANk)單克隆抗體 WB
SEC057Hu 核因子κB受體激活因子(RANk)檢測試劑盒(酶聯(lián)免疫吸附試驗法) Enzyme-linked immunosorbent assay for Antigen Detection.
LMC057Hu 核因子κB受體激活因子(RANk)等多因子檢測試劑盒(流式熒光發(fā)光法) FLIA Kit for Antigen Detection.

參考文獻

雜志 參考文獻
European Journal of Immunology Human polymorphonuclear neutrophils express the receptor activator of NFκB (RANK) and are activated by its ligand RANKL [Wiley: source]
International Journal of Cardiology Valvular osteoclasts in calcification and aortic valve stenosis severity [PubMed: 23452891]
Bulletin? of? Experimental? Biology? and? Medicine Receptor Activator of Nuclear Transcription Factor NF-κB(RANK), Its Ligand RANKL, and Natural Inhibitor of RANKL Osteoprotegerin (OPG) in the Blood Serum of Patients with Primary Bone Tumors [DOI:110.1007/s10517-017-3832-9]
BIOSCIENCE REPORTS IL-38 restrains inflammatory response of collagen-induced arthritis in rats via SIRT1/HIF-1α signaling pathway [Pubmed: 32347300]
留言咨詢
绍兴县| 当雄县| 股票| 石首市| 祁东县| 洛阳市| 偏关县| 金平| 盐边县| 丰城市| 宜君县| 增城市| 宁晋县| 彭泽县| 墨脱县| 新龙县| 泾源县| 阜新市| 新蔡县| 宕昌县| 乐亭县| 宜章县| 成都市| 轮台县| 平舆县| 正镶白旗| 长丰县| 南宫市| 绥阳县| 贺兰县| 兰西县| 陈巴尔虎旗| 射洪县| 临泽县| 巢湖市| 桑日县| 河曲县| 漳州市| 遂宁市| 衡东县| 石狮市|